Elizabeth Henderson
Papers
1
Total Citations
9
H-Index
1
About
Dr. Elizabeth Henderson is a leading expert in stereotactic ablative radiotherapy (SABR), with a particular focus on advanced image-guided techniques for treating thoracic and abdominal tumors. Her most cited work, a seminal 2015 study on the use of platinum fiducial seeds for MRI/CT fusion and real-time tumor tracking during CyberKnife SABR, has garnered 9 citations and established a critical clinical protocol. In this research, Dr. Henderson demonstrated the feasibility and detectability of these fiducials across both MRI and orthogonal x-ray imaging, enabling more precise targeting of mobile tumors. This contribution directly addressed a major challenge in SABR—accounting for respiratory motion—and has been instrumental in improving treatment accuracy and safety. Her work is foundational for clinicians integrating MRI guidance with robotic radiosurgery, bridging the gap between diagnostic imaging and therapeutic delivery. Dr. Henderson’s research continues to shape best practices in stereotactic body radiation therapy, particularly for patients with limited treatment options. Her dedication to refining real-time tumor tracking underscores her impact on modern radiation oncology, making her a key figure in the evolution of non-invasive cancer care.
Research Focus
Key Achievements
Top Papers
- 1